Background/Aims: Hepatocellular carcinoma (HCC) exhibits high de novo recurrence rates post-resection. Current post-surgery recurrence prediction methods are limited, emphasizing the need for reliable biomarkers to assess recurrence risk. We aimed to develop methylation-based markers for classifying HCC patients and predicting their risk of de novo recurrence post-surgery. Methods: In this retrospective cohort study, we analyzed data from HCC patients who underwent surgical resection in Korea, excluding those with recurrence within one year post-surgery. Using the Infinium Methylation EPIC array on 140 samples in the discovery cohort, we classified patients into low- and high-risk groups based on methylation profiles. Distinctive markers were identified through random forest analysis. These markers were validated in the cancer genome atlas (n=217), Validation cohort 1 (n=63) and experimental Validation using a methylation-sensitive high-resolution melting (MS-HRM) assay in Validation cohort 1 and Validation cohort 2 (n=63). Results: The low-risk recurrence group (methylation group 1; MG1) showed a methylation average of 0.73 (95% confidence interval [CI] 0.69–0.77) with a 23.5% recurrence rate, while the high-risk group (MG2) had an average of 0.17 (95% CI 0.14–0.20) with a 44.1% recurrence rate (P<0.03). Validation confirmed the applicability of methylation markers across diverse populations, showing high accuracy in predicting the probability of HCC recurrence risk (area under the curve 96.8%). The MS-HRM assay confirmed its effectiveness in predicting de novo recurrence with 95.5% sensitivity, 89.7% specificity, and 92.2% accuracy. Conclusions Methylation markers effectively classified HCC patients by de novo recurrence risk, enhancing prediction accuracy and potentially offering personalized management strategies.

Background/Aims: Hepatocellular carcinoma (HCC) exhibits high de novo recurrence rates post-resection. Current post-surgery recurrence prediction methods are limited, emphasizing the need for reliable biomarkers to assess recurrence risk. We aimed to develop methylation-based markers for classifying HCC patients and predicting their risk of de novo recurrence post-surgery. Methods: In this retrospective cohort study, we analyzed data from HCC patients who underwent surgical resection in Korea, excluding those with recurrence within one year post-surgery. Using the Infinium Methylation EPIC array on 140 samples in the discovery cohort, we classified patients into low- and high-risk groups based on methylation profiles. Distinctive markers were identified through random forest analysis. These markers were validated in the cancer genome atlas (n=217), Validation cohort 1 (n=63) and experimental Validation using a methylation-sensitive high-resolution melting (MS-HRM) assay in Validation cohort 1 and Validation cohort 2 (n=63). Results: The low-risk recurrence group (methylation group 1; MG1) showed a methylation average of 0.73 (95% confidence interval [CI] 0.69–0.77) with a 23.5% recurrence rate, while the high-risk group (MG2) had an average of 0.17 (95% CI 0.14–0.20) with a 44.1% recurrence rate (P<0.03). Validation confirmed the applicability of methylation markers across diverse populations, showing high accuracy in predicting the probability of HCC recurrence risk (area under the curve 96.8%). The MS-HRM assay confirmed its effectiveness in predicting de novo recurrence with 95.5% sensitivity, 89.7% specificity, and 92.2% accuracy. Conclusions Methylation markers effectively classified HCC patients by de novo recurrence risk, enhancing prediction accuracy and potentially offering personalized management strategies.

Background/Aims: Hepatocellular carcinoma (HCC) exhibits high de novo recurrence rates post-resection. Current post-surgery recurrence prediction methods are limited, emphasizing the need for reliable biomarkers to assess recurrence risk. We aimed to develop methylation-based markers for classifying HCC patients and predicting their risk of de novo recurrence post-surgery. Methods: In this retrospective cohort study, we analyzed data from HCC patients who underwent surgical resection in Korea, excluding those with recurrence within one year post-surgery. Using the Infinium Methylation EPIC array on 140 samples in the discovery cohort, we classified patients into low- and high-risk groups based on methylation profiles. Distinctive markers were identified through random forest analysis. These markers were validated in the cancer genome atlas (n=217), Validation cohort 1 (n=63) and experimental Validation using a methylation-sensitive high-resolution melting (MS-HRM) assay in Validation cohort 1 and Validation cohort 2 (n=63). Results: The low-risk recurrence group (methylation group 1; MG1) showed a methylation average of 0.73 (95% confidence interval [CI] 0.69–0.77) with a 23.5% recurrence rate, while the high-risk group (MG2) had an average of 0.17 (95% CI 0.14–0.20) with a 44.1% recurrence rate (P<0.03). Validation confirmed the applicability of methylation markers across diverse populations, showing high accuracy in predicting the probability of HCC recurrence risk (area under the curve 96.8%). The MS-HRM assay confirmed its effectiveness in predicting de novo recurrence with 95.5% sensitivity, 89.7% specificity, and 92.2% accuracy. Conclusions Methylation markers effectively classified HCC patients by de novo recurrence risk, enhancing prediction accuracy and potentially offering personalized management strategies.

Purpose: This study aims to develop a comprehensive preprocessing workflow for Digital Imaging and Communications in Medicine (DICOM) files to facilitate their effective use in AI-driven medical applications. With the increasing utilization of DICOM data for AI learning, analysis, Metaverse platform integration, and 3D printing of anatomical structures, the need for streamlined preprocessing is essential. The workflow is designed to optimize DICOM files for diverse applications, improving their usability and accessibility for advanced medical technologies. Methods: The proposed workflow employs a systematic approach to preprocess DICOM files for AI applications, focusing on noise reduction, normalization, segmentation, and conversion to 3D-renderable formats. These steps are integrated into a unified process to address challenges such as data variability, format incompatibilities, and high computational demands. The studyincorporates real-world medical imaging datasets to evaluate the workflow’s effectiveness and adaptability for AI analysis and 3D visualization. Additionally, the workflow’s compatibility withvirtual environments, such as Metaverse platforms, is assessed to ensure seamless integration. Results: The implementation of the workflow demonstrated significant improvements in the preprocessing of DICOM files. The processed files were optimized for AI analysis, yielding enhanced model performance and accuracy in learning tasks. Furthermore, the workflow enabled the successful conversion of DICOM data into 3D-printable formats and virtual environments, supporting applications like anatomical visualization and simulation. The study highlights the workflow's ability to reduce preprocessing time and errors, making advanced medical imaging technologies more accessible. Conclusions This study emphasizes the critical role of effective preprocessing in maximizing the potential of DICOM data for AI-driven applications and innovative medical solutions. The proposed workflow simplifies the preprocessing of DICOM files, facilitating their integration into AI models, Metaverse platforms, and 3D printing processes. By enhancing usability and accessibility, the workflow fosters broader adoption of advanced imaging technologies in the medical field.

Purpose: This study aims to develop a comprehensive preprocessing workflow for Digital Imaging and Communications in Medicine (DICOM) files to facilitate their effective use in AI-driven medical applications. With the increasing utilization of DICOM data for AI learning, analysis, Metaverse platform integration, and 3D printing of anatomical structures, the need for streamlined preprocessing is essential. The workflow is designed to optimize DICOM files for diverse applications, improving their usability and accessibility for advanced medical technologies. Methods: The proposed workflow employs a systematic approach to preprocess DICOM files for AI applications, focusing on noise reduction, normalization, segmentation, and conversion to 3D-renderable formats. These steps are integrated into a unified process to address challenges such as data variability, format incompatibilities, and high computational demands. The studyincorporates real-world medical imaging datasets to evaluate the workflow’s effectiveness and adaptability for AI analysis and 3D visualization. Additionally, the workflow’s compatibility withvirtual environments, such as Metaverse platforms, is assessed to ensure seamless integration. Results: The implementation of the workflow demonstrated significant improvements in the preprocessing of DICOM files. The processed files were optimized for AI analysis, yielding enhanced model performance and accuracy in learning tasks. Furthermore, the workflow enabled the successful conversion of DICOM data into 3D-printable formats and virtual environments, supporting applications like anatomical visualization and simulation. The study highlights the workflow's ability to reduce preprocessing time and errors, making advanced medical imaging technologies more accessible. Conclusions This study emphasizes the critical role of effective preprocessing in maximizing the potential of DICOM data for AI-driven applications and innovative medical solutions. The proposed workflow simplifies the preprocessing of DICOM files, facilitating their integration into AI models, Metaverse platforms, and 3D printing processes. By enhancing usability and accessibility, the workflow fosters broader adoption of advanced imaging technologies in the medical field.

Purpose: This study aims to develop a comprehensive preprocessing workflow for Digital Imaging and Communications in Medicine (DICOM) files to facilitate their effective use in AI-driven medical applications. With the increasing utilization of DICOM data for AI learning, analysis, Metaverse platform integration, and 3D printing of anatomical structures, the need for streamlined preprocessing is essential. The workflow is designed to optimize DICOM files for diverse applications, improving their usability and accessibility for advanced medical technologies. Methods: The proposed workflow employs a systematic approach to preprocess DICOM files for AI applications, focusing on noise reduction, normalization, segmentation, and conversion to 3D-renderable formats. These steps are integrated into a unified process to address challenges such as data variability, format incompatibilities, and high computational demands. The studyincorporates real-world medical imaging datasets to evaluate the workflow’s effectiveness and adaptability for AI analysis and 3D visualization. Additionally, the workflow’s compatibility withvirtual environments, such as Metaverse platforms, is assessed to ensure seamless integration. Results: The implementation of the workflow demonstrated significant improvements in the preprocessing of DICOM files. The processed files were optimized for AI analysis, yielding enhanced model performance and accuracy in learning tasks. Furthermore, the workflow enabled the successful conversion of DICOM data into 3D-printable formats and virtual environments, supporting applications like anatomical visualization and simulation. The study highlights the workflow's ability to reduce preprocessing time and errors, making advanced medical imaging technologies more accessible. Conclusions This study emphasizes the critical role of effective preprocessing in maximizing the potential of DICOM data for AI-driven applications and innovative medical solutions. The proposed workflow simplifies the preprocessing of DICOM files, facilitating their integration into AI models, Metaverse platforms, and 3D printing processes. By enhancing usability and accessibility, the workflow fosters broader adoption of advanced imaging technologies in the medical field.

Purpose: This study aims to develop a comprehensive preprocessing workflow for Digital Imaging and Communications in Medicine (DICOM) files to facilitate their effective use in AI-driven medical applications. With the increasing utilization of DICOM data for AI learning, analysis, Metaverse platform integration, and 3D printing of anatomical structures, the need for streamlined preprocessing is essential. The workflow is designed to optimize DICOM files for diverse applications, improving their usability and accessibility for advanced medical technologies. Methods: The proposed workflow employs a systematic approach to preprocess DICOM files for AI applications, focusing on noise reduction, normalization, segmentation, and conversion to 3D-renderable formats. These steps are integrated into a unified process to address challenges such as data variability, format incompatibilities, and high computational demands. The studyincorporates real-world medical imaging datasets to evaluate the workflow’s effectiveness and adaptability for AI analysis and 3D visualization. Additionally, the workflow’s compatibility withvirtual environments, such as Metaverse platforms, is assessed to ensure seamless integration. Results: The implementation of the workflow demonstrated significant improvements in the preprocessing of DICOM files. The processed files were optimized for AI analysis, yielding enhanced model performance and accuracy in learning tasks. Furthermore, the workflow enabled the successful conversion of DICOM data into 3D-printable formats and virtual environments, supporting applications like anatomical visualization and simulation. The study highlights the workflow's ability to reduce preprocessing time and errors, making advanced medical imaging technologies more accessible. Conclusions This study emphasizes the critical role of effective preprocessing in maximizing the potential of DICOM data for AI-driven applications and innovative medical solutions. The proposed workflow simplifies the preprocessing of DICOM files, facilitating their integration into AI models, Metaverse platforms, and 3D printing processes. By enhancing usability and accessibility, the workflow fosters broader adoption of advanced imaging technologies in the medical field.

Purpose: This study aims to develop a comprehensive preprocessing workflow for Digital Imaging and Communications in Medicine (DICOM) files to facilitate their effective use in AI-driven medical applications. With the increasing utilization of DICOM data for AI learning, analysis, Metaverse platform integration, and 3D printing of anatomical structures, the need for streamlined preprocessing is essential. The workflow is designed to optimize DICOM files for diverse applications, improving their usability and accessibility for advanced medical technologies. Methods: The proposed workflow employs a systematic approach to preprocess DICOM files for AI applications, focusing on noise reduction, normalization, segmentation, and conversion to 3D-renderable formats. These steps are integrated into a unified process to address challenges such as data variability, format incompatibilities, and high computational demands. The studyincorporates real-world medical imaging datasets to evaluate the workflow’s effectiveness and adaptability for AI analysis and 3D visualization. Additionally, the workflow’s compatibility withvirtual environments, such as Metaverse platforms, is assessed to ensure seamless integration. Results: The implementation of the workflow demonstrated significant improvements in the preprocessing of DICOM files. The processed files were optimized for AI analysis, yielding enhanced model performance and accuracy in learning tasks. Furthermore, the workflow enabled the successful conversion of DICOM data into 3D-printable formats and virtual environments, supporting applications like anatomical visualization and simulation. The study highlights the workflow's ability to reduce preprocessing time and errors, making advanced medical imaging technologies more accessible. Conclusions This study emphasizes the critical role of effective preprocessing in maximizing the potential of DICOM data for AI-driven applications and innovative medical solutions. The proposed workflow simplifies the preprocessing of DICOM files, facilitating their integration into AI models, Metaverse platforms, and 3D printing processes. By enhancing usability and accessibility, the workflow fosters broader adoption of advanced imaging technologies in the medical field.

Purpose: To present a case of sinonasal neuroendocrine cancer initially manifesting with orbital involvement.Case summary: A 63-year-old female patient visited a neuro-ophthalmologic clinic due to a 3-week history of decreased visual acuity (VA), color vision abnormalities, and swelling of the upper eyelid in right eye. Best-corrected VA (BCVA) in the right eye was 0.8. Clinical findings included a relative afferent pupillary defect, restricted eye movement in lateral, superior, and medial gaze, and exophthalmos in the right eye. Wide-field fundus photography and optical coherence tomography indicated swelling of right optic disc. Magnetic resonance imaging was performed revealing a mass invading nasal cavity, sinus, and right orbital apex, and compressing the medial rectus, inferior rectus, superior oblique, and optic nerve. An otolaryngological nasal biopsy was conducted and immunohistochemical staining showed positive results for Ki-67, NSE, p16, P-53, and CD56, leading to a diagnosis of small cell neuroendocrine carcinoma with an irreducible tumor stage. Prior to initiation of treatment (concurrent chemoradiotherapy, CCRT), there was rapid worsening of VA and eye movement in the right eye. CCRT commenced alongside high-dose steroid treatment. One month following treatment, the BCVA of the right eye improved and protrusion of the right eye resolved. Six months after starting CCRT, a contrast-enhanced orbital computed tomography scan showed no residual lesion. The BCVA of the right eye stabilized at 0.3 with complete recovery of color vision and eye movement. Conclusions Neuroendocrine cancer should be considered as a possible diagnosis in cases of rapidly progressing compressive optic neuropathy.